Mainz Biomed B.V. (MYNZ)
NASDAQ: MYNZ
· Real-Time Price · USD
1.76
0.07 (4.14%)
At close: Aug 15, 2025, 3:59 PM
Mainz Biomed B.V. Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Revenue | 373.22K | 520.77K | 214.76K | 500.21K | 251.4K | 278.48K | 160.04K | 417.31K |
Cost of Revenue | 117.37K | 201.74K | 174.51K | 222.33K | 217.99K | 129.74K | 334.95K | 64.77K |
Gross Profit | 255.84K | 319.04K | 40.25K | 277.88K | 33.41K | 148.74K | -174.92K | 352.54K |
Operating Income | -8.89M | -9.81M | -6.59M | -12.98M | -12.28M | -13.9M | -9.47M | -240.75K |
Interest Income | n/a | n/a | n/a | n/a | 57.5K | 231.83K | 170.12K | 169.05K |
Pretax Income | -10.63M | -11.02M | -5.18M | -13.12M | -12.51M | -13.88M | -11.43M | -240.75K |
Net Income | -10.63M | -11.02M | -5.18M | -13.27M | -12.58M | -13.88M | -11.43M | -240.75K |
Selling & General & Admin | 5.89M | 6.88M | 4.78M | 7.94M | 9.47M | 13.34M | 9.03M | 240.75K |
Research & Development | 2.6M | 3.24M | 2M | 5.25M | 2.96M | 696.29K | 260.54K | 206.15K |
Other Expenses | 656.34K | n/a | n/a | 62.74K | n/a | n/a | 10.75K | 10.75K |
Operating Expenses | 9.14M | 10.13M | 6.49M | 13.25M | 12.45M | 13.91M | 11.08M | 240.75K |
Interest Expense | 1.08M | n/a | n/a | 146.72K | 289.32K | n/a | 84.79K | 84.79K |
Selling & Marketing Expenses | 2.33M | 2.36M | 1.25M | 3.12M | 2.1M | 2.88M | 807.19K | 150.34K |
Cost & Expenses | 9.26M | 10.33M | 6.81M | 13.48M | 12.67M | 14.04M | 11.42M | 240.75K |
Income Tax Expense | n/a | n/a | n/a | 146.72K | -213.14K | n/a | 84.79K | n/a |
Shares Outstanding (Basic) | 968.23K | 558.75K | 442.04K | 29.38M | 14.16M | 13.82M | 8.81M | 12.01M |
Shares Outstanding (Diluted) | 968.23K | 558.75K | 442.04K | 29.38M | 14.16M | 14.29M | 8.81M | 12.01M |
EPS (Basic) | -2.63 | -19.73 | -11.73 | -0.9 | -0.87 | -1 | -1.3 | -0.02 |
EPS (Diluted) | -2.63 | -19.73 | -11.73 | -0.9 | -0.89 | -0.98 | -1.3 | -0.02 |
EBITDA | -10.09M | -9.47M | -4.69M | -12.4M | -11.88M | -13.84M | -9.5M | -219.8K |
EBIT | -10.77M | -9.81M | -4.93M | -12.98M | -12.2M | -13.9M | -9.47M | -254.63K |
Depreciation & Amortization | 680.89K | 336.15K | 407.15K | 574.7K | 404.4K | 55.02K | -28.26K | 34.84K |